Your browser doesn't support javascript.
loading
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.
Simon, Jakub K; Kennedy, Stephen B; Mahon, Barbara E; Dubey, Sheri A; Grant-Klein, Rebecca J; Liu, Ken; Hartzel, Jonathan; Coller, Beth-Ann G; Welebob, Carolee; Hanson, Mary E; Grais, Rebecca F.
  • Simon JK; Merck & Co., Inc., Rahway, NJ, USA.
  • Kennedy SB; Partnership for Research on Ebola Vaccines in Liberia (PREVAIL), Monrovia, Liberia.
  • Mahon BE; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Dubey SA; Merck & Co., Inc., Rahway, NJ, USA.
  • Grant-Klein RJ; Merck & Co., Inc., Rahway, NJ, USA.
  • Liu K; Merck & Co., Inc., Rahway, NJ, USA.
  • Hartzel J; Merck & Co., Inc., Rahway, NJ, USA.
  • Coller BG; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: beth-ann.coller@merck.com.
  • Welebob C; Merck & Co., Inc., Rahway, NJ, USA.
  • Hanson ME; Merck & Co., Inc., Rahway, NJ, USA.
  • Grais RF; Epicentre, Paris, France.
Vaccine ; 40(46): 6599-6606, 2022 11 02.
Article en En | MEDLINE | ID: mdl-36208978
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus Tipo de estudio: Guideline Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus Tipo de estudio: Guideline Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article